Related Experiment Video

Updated: Aug 26, 2026

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses
10:10

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses

Published on: November 16, 2016

Successful treatment of a critically ill patient with disseminated coccidioidomycosis, using adjunctive

Timothy T Kuberski1, Ronald J Servi, Phillip J Rubin

  • 1Good Samaritan Hospital and Medical Center, Phoenix, Arizona, USA.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|March 5, 2004
PubMed

Insights

Interferon-gamma improved a critically ill patient with severe Coccidioides immitis infection when standard antifungal therapy failed. This novel adjunctive treatment led to the patient's recovery and hospital discharge.

Area of Science:

  • Mycology
  • Immunology
  • Infectious Diseases

Background:

  • Disseminated Coccidioides immitis infection is a severe fungal disease.
  • Critically ill patients often require prolonged intensive care unit (ICU) stays.
  • Conventional antifungal therapies can be unsuccessful in severe cases.

Observation:

  • A patient hospitalized for 137 days in the ICU had disseminated Coccidioides immitis and respiratory failure.
  • Standard antifungal treatment was ineffective for this patient.

Findings:

  • The addition of interferon-gamma to the patient's treatment regimen led to clinical improvement.
  • The patient was successfully discharged from the hospital following the adjunctive therapy.

Implications:

  • Interferon-gamma may be a potential adjunctive therapy for severe, refractory coccidioidomycosis.
  • This case highlights a novel therapeutic approach for a life-threatening fungal infection.
  • Further research is warranted to explore the efficacy of interferon-gamma in treating severe fungal infections.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...